{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89968",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Product was distributed to customers in AK and PA.",
      "recall_number": "D-0788-2022",
      "product_description": "Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only,  MFG by: Lupin Pharma, Baltimore, MD 21202.",
      "product_quantity": "433/30 count blister cards, 33/60 count blister cards",
      "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.",
      "recall_initiation_date": "20220406",
      "center_classification_date": "20220426",
      "termination_date": "20220527",
      "report_date": "20220504",
      "code_info": "Lot # B1467803-120621, exp. date 06/30/2022  Lot # J0585793-121721, exp. date 12/31/2022",
      "more_code_info": ""
    }
  ]
}